Loading

PeerCurrent.com|Stay current with the people and research shaping what comes next.

PcPeerCurrent

Your Feed AI Summary Saved Board Expert Discussion This Week in Your Field

Follows Journals Trials Guidelines Markets

Set your cadence Alerts Settings Help

Back to follows

Clinical trial

NCT04556773

1 development in the corpus

NCT04556773

Following this puts new work involving it at the top of your briefing, with a note saying why it is there. Links are taken from the source record, never inferred.

For You Latest Breakthroughs Trials1 Reviews Guidelines

Latest

Everything in the corpus, newest first.

AUG 3, 2026 · PHASE 1 TRIAL

A Phase 1b Study of T-DXd Combinations in HER2-low Advanced or Metastatic Breast Cancer

ClinicalTrials.gov

This is a Phase 1b registry record with no posted results; it describes a planned safety and tolerability study of combination therapies in HER2-low metastatic breast cancer with no efficacy data yet reported.

PreliminaryNCT04556773 Trastuzumab deruxtecan Metastatic Breast Cancer

Reported

Planned enrollment138

Study phasePhase 1b

Primary outcome measure (Part 1 &…Occurrence of adverse events and serious ad…

PeerCurrent.com|Stay current with the people and research shaping what comes next.

About Privacy Terms Support